Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

A descriptive study evaluating Health Canada's risk communications.

Bateman J, Charrois TL, Gardiner P, Vohra S.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1104-9. doi: 10.1002/pds.2137. Epub 2011 Jun 21.

PMID:
21692140
2.
3.

Epidemiology of NHP-drug interactions: identification and evaluation.

Brulotte J, Vohra S.

Curr Drug Metab. 2008 Dec;9(10):1049-54. Review.

PMID:
19075621
4.

Self-reported use of natural health products: a cross-sectional telephone survey in older Ontarians.

Levine MA, Xu S, Gaebel K, Brazier N, B├ędard M, Brazil K, Lohfeld L, MacLeod SM.

Am J Geriatr Pharmacother. 2009 Dec;7(6):383-92. doi: 10.1016/j.amjopharm.2009.12.003.

PMID:
20129259
5.

Natural health product use in Canada: analysis of the National Population Health Survey.

Singh SR, Levine MA.

Can J Clin Pharmacol. 2006 Summer;13(2):e240-50. Epub 2006 Aug 21.

PMID:
16921199
6.

Regulation of natural health products in Canada.

Smith A, Jogalekar S, Gibson A.

J Ethnopharmacol. 2014 Dec 2;158 Pt B:507-10. doi: 10.1016/j.jep.2014.06.037. Epub 2014 Jun 24.

PMID:
24969823
7.

Community identification of natural health product-drug interactions.

Charrois TL, Hill RL, Vu D, Foster BC, Boon HS, Cramer K, Vohra S.

Ann Pharmacother. 2007 Jul;41(7):1124-9. Epub 2007 Jun 19.

PMID:
17578882
8.

The use of natural health products by paediatric patients in respite care.

Beringer A, Vaillancourt R, Villarreal G, Vadeboncoeur C.

Paediatr Child Health. 2015 Jan-Feb;20(1):23-9.

10.

Potential interactions of drug-natural health products and natural health products-natural health products among children.

Goldman RD, Rogovik AL, Lai D, Vohra S.

J Pediatr. 2008 Apr;152(4):521-6, 526.e1-4. doi: 10.1016/j.jpeds.2007.09.026. Epub 2007 Nov 7.

PMID:
18346508
11.

Potential interactions between pharmaceuticals and natural health products in Canada.

Singh SR, Levine MA.

J Clin Pharmacol. 2007 Feb;47(2):249-58.

PMID:
17244776
12.

The effect of complimentary and alternative medicine products on laboratory testing.

Rosecrans R, Dohnal JC.

Semin Diagn Pathol. 2009 Feb;26(1):38-48. Review.

PMID:
19292027
13.

Prevalence of natural health product use in healthy postmenopausal women.

Daoust JL, Mercer LC, Duncan AM.

Menopause. 2006 Mar-Apr;13(2):241-50.

PMID:
16645538
14.

Quality of medicines in Canada: a retrospective review of risk communication documents (2005-2013).

Almuzaini T, Sammons H, Choonara I.

BMJ Open. 2014 Oct 31;4(10):e006088. doi: 10.1136/bmjopen-2014-006088.

16.

The Canadian Natural Health Products (NHP) regulations: industry perceptions and compliance factors.

Laeeque H, Boon H, Kachan N, Cohen JC, D'Cruz J.

BMC Health Serv Res. 2006 May 31;6:63.

17.

Effects of natural health products on blood pressure.

Richard CL, Jurgens TM.

Ann Pharmacother. 2005 Apr;39(4):712-20. Epub 2005 Mar 1. Review.

PMID:
15741425
18.

Health Canada's use of its priority review process for new drugs: a cohort study.

Lexchin J.

BMJ Open. 2015 May 11;5(5):e006816. doi: 10.1136/bmjopen-2014-006816. Erratum in: BMJ Open. 2015;5(9):e006816corr1.

19.

Natural health products in the prevention and treatment of osteoporosis: systematic review of randomized controlled trials.

Whelan AM, Jurgens TM, Bowles SK.

Ann Pharmacother. 2006 May;40(5):836-49. Epub 2006 May 2. Review.

PMID:
16670364
20.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953

Supplemental Content

Support Center